Indeterminate cell histiocytosis successfully treated with phototherapy

Maria Claudia Nogueira Zerbini1, Mirian Nacagami Sotto1, Fernando Peixoto Ferraz de Campos2

  • 1Department of Pathology - Faculty of Medicine - University of São Paulo, São Paulo/SP - Brazil .

Autopsy & Case Reports
|August 23, 2016
PubMed

Insights

Intermediate cell histiocytosis is a rare skin condition involving indeterminate cell proliferation. Narrowband ultraviolet B phototherapy showed excellent short-term results for a patient with this rare disorder.

Area of Science:

  • Dermatology
  • Pathology
  • Immunohistochemistry

Background:

  • Intermediate cell histiocytosis (ICH) is a rare disorder affecting cutaneous dendritic cells.
  • It is characterized by the proliferation of indeterminate cells (ICs).

Observation:

  • A case of a healthy elderly woman with generalized, dome-shaped, reddish cutaneous nodules over 18 months is presented.
  • The patient exhibited no internal organ involvement.
  • Skin biopsy confirmed intermediate cell histiocytosis.

Findings:

  • Immunophenotypically, indeterminate cells (ICs) are positive for CD1a, CD68, and faintly/focally for S100.
  • CD207 (langerin) is negative in these cells.
  • The patient's condition was diagnosed as intermediate cell histiocytosis.

Implications:

  • This case highlights the varied clinical presentation of intermediate cell histiocytosis.
  • Narrowband ultraviolet B phototherapy demonstrated an excellent short-term outcome for this rare cutaneous disorder.
  • Further research into long-term efficacy and alternative treatments for ICH is warranted.